Targeting tumor-intrinsic hexosamine biosynthesis sensitizes pancreatic cancer to anti-PD1 therapy
Nikita Sharma(University of Miami), Sulagna Banerjee(University of Miami)
Cited by 211
Related Papers
Hypoxia-Driven Oncometabolite L-2HG Maintains Stemness-Differentiation Balance and Facilitates Immune Evasion in Pancreatic Cancer
|Cancer Research|2021|83
miR-204 mediated loss of Myeloid cell leukemia-1 results in pancreatic cancer cell death
|Molecular Cancer|2013|64
Triptolide sensitizes pancreatic cancer cells to TRAIL-induced activation of the Death Receptor pathway
|Cancer Letters|2014|64
O-GlcNAc modification of Sox2 regulates self-renewal in pancreatic cancer by promoting its stability
|Theranostics|2019|63
O-GlcNAc modification of oncogenic transcription factor Sox2 promotes protein stability and regulates self-renewal in pancreatic cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2018|7